Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 19651-19700 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05941520
Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
PHASE2
Recruiting
80 participants
Started: Aug 23, 2024 · Completed: Sep 1, 2028
4 conditions
1 sponsor
4 locations
NCT06566521
Thoracic Paravertebral Block in Daytime Laparoscopic Partial Adrenalectomy
NA
Recruiting
80 participants
Started: Aug 23, 2024 · Completed: Nov 15, 2024
2 conditions
1 sponsor
1 location
NCT06538623
Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
PHASE2
Recruiting
40 participants
Started: Aug 23, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06331208
Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure
N/A
Recruiting
230 participants
Started: Aug 23, 2024 · Completed: Dec 30, 2026
3 conditions
1 sponsor
1 location
NCT06283420
Metabolic Response to the Initiation of Heart Failure Therapy
N/A
Recruiting
120 participants
Started: Aug 23, 2024 · Completed: Dec 20, 2026
1 condition
1 sponsor
1 location
NCT06299202
Contrast-enhanced Spectral Mammography (CESM) Early Quantitative Evaluation of Tumoral Response and Pathologic Complete Response Prediction for Localized Breast Cancer Treated by Neoadjuvant Chemotherapy
NA
Recruiting
100 participants
Started: Aug 23, 2024 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT06610526
A Study of Dapagliflozin in Chinese Adult Patients With Chronic Kidney Disease
PHASE4
Recruiting
700 participants
Started: Aug 23, 2024 · Completed: Apr 27, 2027
1 condition
1 sponsor
37 locations
NCT06223555
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
NA
Recruiting
79 participants
Started: Aug 23, 2024 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06436326
The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes
NA
Recruiting
120 participants
Started: Aug 22, 2024 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT05322213
THC Effects on Glucose in Type 2 Diabetes
PHASE1
Recruiting
30 participants
Started: Aug 22, 2024 · Completed: Jun 30, 2028
1 condition
2 sponsors
1 location
NCT06532253
Long-term Safety Trial with NVDX3
PHASE1/PHASE2
Recruiting
15 participants
Started: Aug 22, 2024 · Completed: Mar 31, 2036
2 conditions
3 sponsors
1 location
NCT06475989
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
PHASE3
Recruiting
264 participants
Started: Aug 22, 2024 · Completed: Sep 30, 2030
1 condition
2 sponsors
112 locations
NCT06574594
Effect of MTX Discontinuation on Shingrix Response in RA
NA
Recruiting
110 participants
Started: Aug 22, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT07064174
Sickle Cell Kidney Biorepository
N/A
Recruiting
800 participants
Started: Aug 22, 2024 · Completed: Dec 31, 2049
3 conditions
1 sponsor
2 locations
NCT06668714
Does Co-administration of Lactate Affect Postprandial Nutrient Absorption and Fat Disposition?
NA
Recruiting
25 participants
Started: Aug 22, 2024 · Completed: Jan 31, 2026
2 conditions
1 sponsor
1 location
NCT04974138
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
PHASE4
Recruiting
32,000 participants
Started: Aug 22, 2024 · Completed: Jun 30, 2030
4 conditions
22 sponsors
20 locations
NCT06225284
Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer Patients
PHASE2
Recruiting
124 participants
Started: Aug 22, 2024 · Completed: Dec 31, 2030
2 conditions
3 sponsors
1 location
NCT06532812
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
PHASE1/PHASE2
Recruiting
85 participants
Started: Aug 22, 2024 · Completed: Dec 28, 2026
4 conditions
1 sponsor
1 location
NCT06546631
Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological Toxicity for Glioma Patients
N/A
Recruiting
55 participants
Started: Aug 22, 2024 · Completed: Feb 28, 2027
1 condition
2 sponsors
1 location
NCT04974151
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
PHASE4
Recruiting
24,000 participants
Started: Aug 22, 2024 · Completed: Jun 30, 2029
2 conditions
22 sponsors
20 locations
NCT06342141
Empagliflozin for No-reflow Phenomenon in PCI for STEMI
PHASE2
Recruiting
162 participants
Started: Aug 22, 2024 · Completed: Oct 15, 2025
2 conditions
1 sponsor
1 location
NCT05843253
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
PHASE2
Recruiting
120 participants
Started: Aug 22, 2024 · Completed: Aug 28, 2034
10 conditions
2 sponsors
18 locations
NCT06535607
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
PHASE2
Recruiting
257 participants
Started: Aug 22, 2024 · Completed: Nov 30, 2028
2 conditions
1 sponsor
50 locations
NCT06666621
Endogenous Opioid Response to Injections
PHASE4
Recruiting
33 participants
Started: Aug 22, 2024 · Completed: Feb 28, 2026
2 conditions
2 sponsors
1 location
NCT06594120
Changes in Workability and Employment Following the Work-related Medical Rehabilitation PV RehaJET
N/A
Recruiting
300 participants
Started: Aug 22, 2024 · Completed: Oct 1, 2026
1 condition
1 sponsor
1 location
NCT07029893
Independent Life Skills Program for Adults With Autism Spectrum Disorder
NA
Recruiting
32 participants
Started: Aug 22, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06357182
Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
PHASE1
Recruiting
24 participants
Started: Aug 22, 2024 · Completed: May 29, 2026
2 conditions
3 sponsors
1 location
NCT06452719
Letrozole and Misoprostol for Early Pregnancy Loss Management
PHASE2
Recruiting
30 participants
Started: Aug 22, 2024 · Completed: Jul 15, 2026
3 conditions
1 sponsor
1 location
NCT06402344
Gestrinone and Endothelial Function in Young Women
N/A
Recruiting
90 participants
Started: Aug 22, 2024 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT06568042
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
PHASE2
Recruiting
450 participants
Started: Aug 22, 2024 · Completed: Sep 30, 2026
2 conditions
1 sponsor
76 locations
NCT06415487
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
PHASE1
Recruiting
30 participants
Started: Aug 22, 2024 · Completed: Mar 27, 2027
2 conditions
1 sponsor
9 locations
NCT06592326
9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
PHASE3
Recruiting
460 participants
Started: Aug 22, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06185751
Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
PHASE1
Recruiting
25 participants
Started: Aug 22, 2024 · Completed: Aug 31, 2040
1 condition
2 sponsors
1 location
NCT06530849
A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus
PHASE1/PHASE2
Recruiting
118 participants
Started: Aug 22, 2024 · Completed: Feb 1, 2027
1 condition
3 sponsors
2 locations
NCT06533059
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
PHASE1
Recruiting
110 participants
Started: Aug 22, 2024 · Completed: Dec 29, 2027
5 conditions
1 sponsor
49 locations
NCT06471075
Brief Mindfulness Intervention for Pain Before an In-clinic Orthopedic Procedure
NA
Recruiting
80 participants
Started: Aug 22, 2024 · Completed: Sep 11, 2026
3 conditions
1 sponsor
1 location
NCT06542445
The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
PHASE2
Recruiting
120 participants
Started: Aug 22, 2024 · Completed: Sep 22, 2026
1 condition
1 sponsor
1 location
NCT06401148
Exercise-based Cardiac Rehabilitation for Atrial Fibrillation
NA
Recruiting
60 participants
Started: Aug 22, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06153667
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)
N/A
Recruiting
100 participants
Started: Aug 22, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06704048
Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.
NA
Recruiting
50 participants
Started: Aug 22, 2024 · Completed: Aug 31, 2035
4 conditions
1 sponsor
1 location
NCT06297499
Ondansetron Use for Preventing Pruritus in Patients Undergoing Cesarean Section
PHASE1
Recruiting
66 participants
Started: Aug 22, 2024 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06568744
Fluid Intolerance Signals as Safety Limits to Prevent Fluid-induced Harm During Septic Shock Resuscitation
NA
Recruiting
62 participants
Started: Aug 22, 2024 · Completed: Jul 31, 2026
1 condition
1 sponsor
3 locations
NCT06494072
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
PHASE4
Recruiting
236 participants
Started: Aug 22, 2024 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT05679271
Dural Sinus Stenting of Low Grade Dural Arteriovenous Fistulae (DAVF) for Pulsatile Tinnitus Treatment
NA
Recruiting
48 participants
Started: Aug 22, 2024 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT06433947
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
PHASE1
Recruiting
130 participants
Started: Aug 22, 2024 · Completed: Jul 31, 2026
2 conditions
1 sponsor
10 locations
NCT06581601
Physiotherapy Management in Women With Urinary Incontinence
NA
Recruiting
300 participants
Started: Aug 21, 2024 · Completed: Nov 20, 2027
1 condition
1 sponsor
1 location
NCT06782841
The Effects of GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask in Surgeries With Lateral Position Under General Anesthesia
NA
Recruiting
102 participants
Started: Aug 21, 2024 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT06766253
The Effects of GMA-TULIP, I-gel, and BlockBuster Laryngeal Mask in Laparoscopic Surgeries With Trendelenburg Position Under General Anesthesia
NA
Recruiting
195 participants
Started: Aug 21, 2024 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT06796634
Effects of Cold Atmospheric Plasma (CAP) on Peritoneal Tumor Tissue
NA
Recruiting
5 participants
Started: Aug 21, 2024 · Completed: Apr 1, 2025
3 conditions
1 sponsor
1 location
NCT06290141
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PHASE3
Recruiting
160 participants
Started: Aug 21, 2024 · Completed: Nov 19, 2027
1 condition
1 sponsor
92 locations
Previous
1
More pages
391
392
393
394
395
396
397
More pages
1333
Next